Displaying drugs 2476 - 2500 of 2597 in total
Melevodopa
Experimental
Matched Iupac: … methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate …
Matched Categories: … Dopamine Agents ... Anti-Dyskinesia Agents ... Dopa and Dopa Derivatives ... Central Nervous System Agents ... Amino Acids, Peptides, and Proteins …
Matched Categories: … Dopamine Agents ... Anti-Dyskinesia Agents ... Dopa and Dopa Derivatives ... Central Nervous System Agents ... Amino Acids, Peptides, and Proteins …
Beloranib
Beloranib has been used in trials studying the treatment of Obesity, Over-weight, Type 2 Diabetes, Craniopharyngioma, and Hypothalamic Injury, among others.
Investigational
Matched Iupac: … (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan ... -6-yl (2E)-3-{4-[2-(dimethylamino)ethoxy]phenyl}prop-2-enoate …
Matched Description: … used in trials studying the treatment of Obesity, Over-weight, Type 2 Diabetes, Craniopharyngioma, and …
Matched Categories: … Antineoplastic Agents ... Angiogenesis Modulating Agents …
Matched Description: … used in trials studying the treatment of Obesity, Over-weight, Type 2 Diabetes, Craniopharyngioma, and …
Matched Categories: … Antineoplastic Agents ... Angiogenesis Modulating Agents …
Thiopropazate
Experimental
Matched Iupac: … 2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethyl acetate …
Matched Categories: … Heterocyclic Compounds, 3-Ring ... Antipsychotic Agents ... Neurotoxic agents …
Matched Categories: … Heterocyclic Compounds, 3-Ring ... Antipsychotic Agents ... Neurotoxic agents …
Peficitinib
Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics, Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others.
Investigational
Matched Description: … , Drug Interactions, Colitis, Ulcerative, and RHEUMATOID ARTHRITIS, among others. ... Peficitinib has been used in trials studying the treatment and basic science of Psoriasis, Pharmacodynamics …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Immunosuppressive Agents …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Immunosuppressive Agents …
Lortalamine
Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental
Matched Description: … Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. …
Matched Categories: … Antidepressive Agents …
Matched Categories: … Antidepressive Agents …
Firategrast
Firategrast has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Iupac: … (2S)-2-[(2,6-difluorophenyl)formamido]-3-[4'-(ethoxymethyl)-2',6'-dimethoxy-[1,1'-biphenyl]-4-yl]propanoic …
Matched Categories: … Anti-Inflammatory Agents ... Amino Acids, Peptides, and Proteins …
Matched Categories: … Anti-Inflammatory Agents ... Amino Acids, Peptides, and Proteins …
Cloricromen
Experimental
Matched Iupac: … ethyl 2-({8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-chromen-7-yl}oxy)acetate …
Matched Categories: … Blood and Blood Forming Organs ... Antiplatelet agents ... Hematologic Agents …
Matched Categories: … Blood and Blood Forming Organs ... Antiplatelet agents ... Hematologic Agents …
Otamixaban
Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.
Investigational
Matched Iupac: … 4-(4-{[(2R,3R)-3-[(3-carbamimidoylphenyl)methyl]-4-methoxy-4-oxobutan-2-yl]carbamoyl}phenyl)pyridin-1 …
Matched Description: … Otamixaban is a novel direct Factor Xa (FXa) inhibitor. ... It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for …
Matched Categories: … Hematologic Agents …
Matched Description: … Otamixaban is a novel direct Factor Xa (FXa) inhibitor. ... It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for …
Matched Categories: … Hematologic Agents …
Bietaserpine
Experimental
Matched Iupac: … methyl (1R,15S,17R,18R,19S,20S)-3-[2-(diethylamino)ethyl]-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy …
Matched Categories: … bietaserpine and diuretics ... Cardiovascular Agents ... Antihypertensive Agents ... Antiadrenergic Agents, Centrally Acting …
Matched Categories: … bietaserpine and diuretics ... Cardiovascular Agents ... Antihypertensive Agents ... Antiadrenergic Agents, Centrally Acting …
Prednimustine
Prednimustine has been used in trials studying the treatment of Lymphoma.
Investigational
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Antineoplastic Agents ... Antineoplastic Agents, Alkylating …
Mitiglinide
Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.
Investigational
Matched Description: … Mitiglinide is a drug for the treatment of type 2 diabetes. …
Matched Categories: … Blood Glucose Lowering Agents ... Alimentary Tract and Metabolism …
Matched Categories: … Blood Glucose Lowering Agents ... Alimentary Tract and Metabolism …
Demoxytocin
Experimental
Matched Categories: … Uterotonic agents ... Reproductive Control Agents ... Pituitary and Hypothalamic Hormones and Analogues ... Oxytocin and Analogues ... Sex Hormones and Insulins …
Metahexamide
Experimental
Matched Iupac: … 3-(3-amino-4-methylbenzenesulfonyl)-1-cyclohexylurea …
Matched Categories: … Alimentary Tract and Metabolism ... Blood Glucose Lowering Agents …
Matched Categories: … Alimentary Tract and Metabolism ... Blood Glucose Lowering Agents …
Lecozotan
Lecozotan has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Categories: … Antidepressive Agents ... Serotonin Agents …
Ibipinabant
Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.
Investigational
Matched Iupac: … (4S)-N'-(4-chlorobenzenesulfonyl)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide …
Matched Description: … Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes …
Matched Categories: … Agents producing tachycardia ... Cannabinoids and similars ... Neurotransmitter Agents ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Matched Description: … Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes …
Matched Categories: … Agents producing tachycardia ... Cannabinoids and similars ... Neurotransmitter Agents ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Quinbolone
Experimental
Matched Categories: … Alimentary Tract and Metabolism ... Anabolic Agents for Systemic Use …
Kitasamycin
Kitasamycin is a macrolide antibiotic derived from Streptomyces kitasatoensis.
Experimental
Matched Iupac: … yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate ... oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3- …
Matched Description: … Kitasamycin is a macrolide antibiotic derived from Streptomyces kitasatoensis. …
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents …
Matched Description: … Kitasamycin is a macrolide antibiotic derived from Streptomyces kitasatoensis. …
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents …
Imagabalin
Imagabalin has been investigated in Generalized Anxiety Disorder.
Investigational
Matched Iupac: … (3S,5R)-3-amino-5-methyloctanoic acid …
Matched Categories: … Anti-Anxiety Agents ... Amino Acids, Peptides, and Proteins …
Matched Categories: … Anti-Anxiety Agents ... Amino Acids, Peptides, and Proteins …
Letosteine
Letosteine is a mucolytic used in the treatment of chronic bronchopneumopathies and related conditions.
Experimental
Matched Description: … Letosteine is a mucolytic used in the treatment of chronic bronchopneumopathies and related conditions …
Matched Categories: … Cough and Cold Preparations ... Respiratory System Agents …
Matched Categories: … Cough and Cold Preparations ... Respiratory System Agents …
Furazidin
Experimental
Matched Iupac: … 1-[(E)-[(2E)-3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino]imidazolidine-2,4-dione …
Matched Categories: … Anti-Infective Agents ... Anti-Infective Agents, Urinary …
Matched Categories: … Anti-Infective Agents ... Anti-Infective Agents, Urinary …
Nifurtoinol
Experimental
Matched Iupac: … 3-(hydroxymethyl)-1-[(E)-[(5-nitrofuran-2-yl)methylidene]amino]imidazolidine-2,4-dione …
Matched Categories: … Anti-Infective Agents ... Anti-Infective Agents, Urinary …
Matched Categories: … Anti-Infective Agents ... Anti-Infective Agents, Urinary …
Bisindolylmaleimide VIII
Experimental
Matched Iupac: … 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione …
Matched Categories: … Antiplatelet agents ... Hematologic Agents …
Matched Categories: … Antiplatelet agents ... Hematologic Agents …
Glibornuride
Glibornuride is a sulfonylurea-type anti-diabetic drug.
Investigational
Withdrawn
Matched Iupac: … 3-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-1-(4-methylbenzenesulfonyl)urea …
Matched Description: … Glibornuride is a sulfonylurea-type anti-diabetic drug. …
Matched Categories: … Alimentary Tract and Metabolism ... Blood Glucose Lowering Agents …
Matched Description: … Glibornuride is a sulfonylurea-type anti-diabetic drug. …
Matched Categories: … Alimentary Tract and Metabolism ... Blood Glucose Lowering Agents …
Camostat
Camostat mesylate, or FOY-305, is a synthetic serine protease inhibitor.[A193842,A193848] It was first described in the literature in 1981, as part of research on the inhibition of skin tumors in mice. Camostat mesylate inhibits cholecystokinin, pro-inflammatory cytokines, and serine proteases, leading to it being investigated for multiple indications including the...
Experimental
Matched Description: … Camostat mesylate, or FOY-305, is a synthetic serine protease inhibitor. ... [A198807] Camostat mesylate inhibits cholecystokinin, pro-inflammatory cytokines, and serine proteases …
Matched Categories: … Antifibrinolytic Agents ... Blood and Blood Forming Organs …
Matched Categories: … Antifibrinolytic Agents ... Blood and Blood Forming Organs …
Norgestrienone
Experimental
Matched Iupac: … (1R,3aS,3bS,11aS)-1-ethynyl-1-hydroxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta[a]phenanthren …
Matched Categories: … Contraceptive Agents, Female ... Reproductive Control Agents ... Genito Urinary System and Sex Hormones ... Sex Hormones and Modulators of the Genital System ... Combination Contraceptives (with Estrogen and derivatives) …
Matched Categories: … Contraceptive Agents, Female ... Reproductive Control Agents ... Genito Urinary System and Sex Hormones ... Sex Hormones and Modulators of the Genital System ... Combination Contraceptives (with Estrogen and derivatives) …
Displaying drugs 2476 - 2500 of 2597 in total